Nasal secretions in response to acetylsalicylic acid.

[1]  R. Naclerio,et al.  Mediator release after nasal airway challenge with allergen. , 2015, The American review of respiratory disease.

[2]  D. Stevenson,et al.  Tryptase and histamine release during aspirin-induced respiratory reactions. , 1991, The Journal of allergy and clinical immunology.

[3]  M. Kaliner,et al.  The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. , 1991, The Journal of allergy and clinical immunology.

[4]  A. Ford-hutchinson,et al.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. , 1991, The American review of respiratory disease.

[5]  M. Kaliner,et al.  How and why the nose runs. , 1991, The Journal of allergy and clinical immunology.

[6]  W. Hosemann,et al.  ASA-induced release of histamine from nasal mucous membranes in analgesic intolerance and polyposis nasi. , 1990, Rhinology.

[7]  J. Fink,et al.  Surgery for sinusitis and aspirin triad , 1990, The Laryngoscope.

[8]  A. Miyatake,et al.  Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma. , 1990, The Journal of allergy and clinical immunology.

[9]  M. Kaliner,et al.  Abnormal nasal glandular secretion in recurrent sinusitis. , 1990, The Journal of allergy and clinical immunology.

[10]  M. Kaliner,et al.  Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. , 1989, The Journal of clinical investigation.

[11]  J. Arm,et al.  Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. , 1989, The American review of respiratory disease.

[12]  M. Kaliner,et al.  The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. , 1989, The American review of respiratory disease.

[13]  M. Chan-yeung,et al.  Release of Histamine, Prostaglandins, and Leukotrienes after Antigen Challenge in Hayfever Subjects , 1988 .

[14]  D. Stevenson,et al.  Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. , 1988, The American review of respiratory disease.

[15]  M. Kaliner,et al.  The Airways: Neural Control in Health and Disease , 1987 .

[16]  A. Sala,et al.  Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. , 1987, The American review of respiratory disease.

[17]  M. Kowalski,et al.  Fibrinolysis, blood coagulation, and platelet function during aspirin-induced bronchoconstriction in aspirin-intolerant asthmatics. , 1987, Annals of allergy.

[18]  S. Spector,et al.  Histopathology and immunofluorescent immunoglobulins in asthmatics with aspirin idiosyncrasy. , 1987, Archives of otolaryngology--head & neck surgery.

[19]  S. Juhn,et al.  Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa , 1987, The Laryngoscope.

[20]  K. Strandberg,et al.  Histamine concentrations in nasal secretion and secretory activity in allergic rhinitis , 1987, Allergy.

[21]  M. Kowalski,et al.  Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics. , 1986, European journal of respiratory diseases.

[22]  A. Togias,et al.  Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. , 1986, The American review of respiratory disease.

[23]  E. Goetzl,et al.  Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. , 1986, The Journal of allergy and clinical immunology.

[24]  G. English.  Nasal polypectomy and sinus surgery in patients with asthma and aspirin idiosyncrasy , 1986, The Laryngoscope.

[25]  M. Kowalski,et al.  Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation. , 1985, Thorax.

[26]  A. Togias,et al.  Inflammatory mediators in late antigen-induced rhinitis. , 1985, The New England journal of medicine.

[27]  A. Wardlaw,et al.  Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic Rhinitis , 1985, Allergy.

[28]  E. Pastorello,et al.  Neutrophil chemotactic factor of anaphylaxis (NCF‐A) release in aspirin‐induced asthma , 1984, Clinical allergy.

[29]  S. Braman,et al.  Identification and characterization of neutrophil chemotactic activity in aspirin-induced asthma. , 1984, The American review of respiratory disease.

[30]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[31]  R. Simon,et al.  Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin. , 1984, The Journal of allergy and clinical immunology.

[32]  M. Kowalski,et al.  Aspirin Tolerance Induced in Aspirin‐Sensitive Asthmatics , 1984, Allergy.

[33]  D. Stevenson,et al.  Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. , 1983, The Journal of allergy and clinical immunology.

[34]  R. Simon,et al.  Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. , 1983, The Journal of allergy and clinical immunology.

[35]  Slavin Rg.  Relationship of nasal disease and sinusitis to bronchial asthma. , 1982 .

[36]  M. Kowalski,et al.  Asthma with aspirin intolerance. Clinical entity or coincidence of nonspecific bronchial hyperreactivity and aspirin intolerance. , 1981, Allergologia et immunopathologia.

[37]  S. Spector,et al.  Aspirin and concomitant idiosyncrasies in adult asthmatic patients. , 1979, The Journal of allergy and clinical immunology.

[38]  E. Tan,et al.  Oral aspirin challenges in asthmatic patients: a study of plasma histamine , 1976, Clinical allergy.

[39]  A. Szczeklik,et al.  Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. , 1975, British medical journal.

[40]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[41]  J. Davies,et al.  Diagnostic and therapeutic problems of parathion poisonings. , 1968, Annals of internal medicine.

[42]  J. Montserrat,et al.  Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. , 1992, The American review of respiratory disease.

[43]  R. Simon,et al.  Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma. , 1990, The Journal of allergy and clinical immunology.

[44]  T. Yamashita,et al.  Etiology of nasal polyps associated with aspirin-sensitive asthma. , 1989, Rhinology. Supplement.

[45]  A. Szczeklik.  Origin of aspirin-induced asthma. , 1989, Agents and actions. Supplements.

[46]  M. Béné,et al.  Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. , 1989, Rhinology. Supplement.

[47]  U. Pipkorn,et al.  Allergic and vasomotor rhinitis : pathophysiological aspects , 1987 .

[48]  T. Harada,et al.  Aspirin-induced asthma and nasal polyps. , 1986, Acta oto-laryngologica. Supplementum.

[49]  G. Settipane.  Asthma, aspirin intolerance and nasal polyps. , 1986, New England and regional allergy proceedings.

[50]  M. Kaliner,et al.  29 Methacholine-induced histamine release in nasal secretions , 1985 .

[51]  R. Simon,et al.  232 Plasma mediator studies in aspirin sensitive asthma: Lack of a role for the mast cell , 1983 .

[52]  T. Palva,et al.  Nasal polyposis. Relationships to allergy and acetylsalicyclic acid intolerance. , 1979, Acta oto-laryngologica.

[53]  J. Hendley,et al.  Histamine in nasal secretions. , 1978, International archives of allergy and applied immunology.